Medigus ltd. (MDGS)
CashFlow / Quarterly
Jun'18Jun'17
CASH FLOWS FROM OPERATING ACTIVITIES:
Cash flows used in operations (see Appendix)

-994

-1,453

Interest received

36

0

Income tax paid

4

13

Net cash flow used in operating activities

-962

-1,466

CASH FLOWS FROM INVESTING ACTIVITIES:
Investment in short-term deposits

0

5,543

Withdrawal of short-term deposits

3,498

1,000

Purchase of intangible assets

2

0

Net cash flow generated from (used in) investing activities

3,496

-4,543

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of shares and warrants, net of issuances costs

0

0

Proceeds from exercise of warrants

0

6

Net cash flow generated from financing activities

0

6

INCREASE (DECREADE) IN CASH AND CASH EQUIVALENTS

2,534

-6,003

GAIN (LOSS) FROM EXCHANGE DIFFERENCES ON CASH AND CASH EQUIVALENTS

-22

27

Supplementary information on activities not involving cash flows -
Exercise of warrants

0

1,076

Net cash used in operations:
Profit (loss) for the period before taxes on income

-1,138

801

Adjustment in respect of:
Retirement benefit obligation, net

-3

7

Inventory impairment

99

0

Depreciation

8

16

Amortization

2

4

Loss (gain) from exchange differences on cash and cash equivalents

22

-27

Interest received

-36

0

Stock-based compensation in connection with options granted to employees and service providers

39

6

Loss (profit) on change in the fair value of warrants issued to investors

38

-2,137

Issuance expenses which were attributed to the warrants classified as a financial liability and charged directly to profit or loss

0

0

Changes in operating asset and liability items:
Decrease (increase) in accounts receivables - trade

-19

46

Decrease (increase) in other current assets

-6

160

Decrease in accounts payable - trade and contract liability

-16

-47

Increase (decrease) in other current liabilities

20

-178

Decrease (increase) in inventory

-4

-104

Net cash used in operations

-994

-1,453